Amgen Inc. (AMGN) vs Gilead Sciences, Inc. (GILD)
- Amgen Inc. AMGN 432.49 −0.35%
- Gilead Sciences, Inc. GILD 156.19 −0.75%
Amgen Inc. and Gilead Sciences, Inc. are both Drug Manufacturers General companies. Amgen Inc. is the larger, with a market value of $234.7B against $195.1B — 1.2× the size. Gilead Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Amgen Inc. trades at 26.7×. Amgen Inc. grew revenue faster over the last twelve months: 9.10% against 5.52%. Amgen Inc. has the higher net margin (23.0% vs −10.6%) and the higher return on invested capital (13.0% vs −4.48%). Both pay a dividend; Amgen Inc. yields more (2.30% vs 2.08%). Across the 22 metrics below, Amgen Inc. leads on 12 and Gilead Sciences, Inc. on 10.
Valuation
Profitability
| Metric | AMGN | GILD | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 69.52% | 79.59% | 72.77% |
| Operating margin | 29.99% | (8.20%) | 18.77% |
| Net margin | 22.95% | (10.64%) | 8.27% |
| Free cash flow margin | 26.71% | 42.50% | 17.18% |
| Return on equity | 91.47% | (20.68%) | 5.87% |
| Return on assets | 9.53% | (6.17%) | 2.57% |
| Return on invested capital | 12.98% | (4.48%) | 6.11% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack